Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial

Takashi Kadowaki, Soo Lim, Usman Khalid et al.|The Lancet Diabetes & Endocrinology|2022

Cited by 319